Study details
Enrolling now
Excision of Lymph Node Trial (EXCILYNT)
Craig L Slingluff, Jr
NCT IDNCT05839912ClinicalTrials.gov data as of Apr 2026
Target enrollment
66
Study length
about 5 years
Ages
18+
Locations
7 sites in GA, MD, MI +4
About this study
Researchers are testing whether removing cancerous lymph nodes after treatment can prevent cancer from returning. The trial also aims to understand the side effects of this surgery and its impact on quality of life.
Based on ClinicalTrials.gov records.
What participants do
- 1.Undergo Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
- 2.Undergo Excision of clinically detected lymph node metastasis before any systemic therapy
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
surgery
Body systems
Oncology